These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 11143298)

  • 21. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
    Lee JM; Lee KB; Lee SK; Park CY
    J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
    Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
    Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
    Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
    Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
    Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
    Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
    Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
    Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopausal status: a possible predictive factor for recurrence in women with cancer of the uterine cervix without pelvic lymph node metastasis.
    Fregnani JH; Latorre MR; Novik PR; Lopes A; Soares FA
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):204-9. PubMed ID: 19450920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
    Scambia G; Ferrandina G; Distefano M; Fagotti A; Manfredi R; Zannoni GF; Mancuso S
    Gynecol Oncol; 2001 Nov; 83(2):319-24. PubMed ID: 11606092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
    Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
    J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and prognostic factors of node-negative cervical cancer patients with deep stromal invasion or lymphovascular space involvement following radical hysterectomy.
    Suprasert P; Srisomboon J; Siriaunkgul S; Khunamornpong S; Phongnarisorn C; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Kietpeerakool C
    J Med Assoc Thai; 2006 Sep; 89(9):1368-75. PubMed ID: 17100371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.
    Juretzka MM; Jensen KC; Longacre TA; Teng NN; Husain A
    Gynecol Oncol; 2004 Apr; 93(1):107-11. PubMed ID: 15047221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy.
    Gerdin E; Cnattingius S; Johnson P; Pettersson B
    Gynecol Oncol; 1994 Jun; 53(3):314-9. PubMed ID: 8206404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.